Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

13.20
BATS BZX Real-Time Price
As of 9:51am ET
 +0.10 / +0.76%
Today’s Change
10.52
Today|||52-Week Range
19.98
+7.58%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close13.10
Today’s open13.01
Day’s range12.99 - 13.20
Volume2,531
Average volume (3 months)1,569,590
Market cap$2.0B
Dividend yield--
Data as of 9:51am ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-81.97%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book275.67

Competitors

 Today’s
change
Today’s
% change
ONCESpark Therapeutics I...+0.31+0.48%
RDUSRadius Health Inc-0.05-0.11%
EXASExact Sciences Corp+2.69+13.51%
AVXSAveXis Inc+0.25+0.41%
Data as of 9:52am ET, 02/21/2017

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts


Search for Jobs